ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
66,128.49
0.19%
S&P 500
5,431.60
-0.04%
Dow Jones
38,589.16
-0.15%
US Dollar vs Yen
157.405
-0.01%
Brent Oil
82.275
0.00%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. USOTC
  6. Skye Bioscience Inc (QB) (SKYE)

  7. Skye Bioscience Inc (QB) (SKYE) ニュース

SKYE

Skye Bioscience (QB) (SKYE)

Skye Bioscience Inc (QB)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:USOTC:SKYE
日付受信時刻ニュースソース見出しコード企業名
2024/03/0509 : 53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
2024/03/0508 : 02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
2024/03/0508 : 01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
2024/03/0506 : 23Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SKYESkye Bioscience Inc (QB)
2024/03/0506 : 18Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
2024/03/0506 : 04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
2024/03/0420 : 23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
2024/03/0420 : 19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
2024/03/0420 : 17Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
2024/03/0420 : 15Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]USOTC:SKYESkye Bioscience Inc (QB)
2024/03/0208 : 42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
2024/02/1306 : 18Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SKYESkye Bioscience Inc (QB)
2024/02/1302 : 08Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:SKYESkye Bioscience Inc (QB)
2024/02/0306 : 35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
2024/02/0106 : 15Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]USOTC:SKYESkye Bioscience Inc (QB)
2024/01/2922 : 02Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SKYESkye Bioscience Inc (QB)
2023/12/0607 : 04Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SKYESkye Bioscience Inc (QB)
2023/11/0710 : 32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
2023/11/0710 : 30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
2023/11/0710 : 29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
2023/11/0710 : 29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
2023/11/0710 : 29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
2023/10/0405 : 34Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SKYESkye Bioscience Inc (QB)
2023/10/0405 : 12Edgar (US Regulatory)Form PRE 14C - Other preliminary information statementsUSOTC:SKYESkye Bioscience Inc (QB)
2023/09/0802 : 15Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SKYESkye Bioscience Inc (QB)
2023/08/3010 : 36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
2023/08/3008 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
2023/08/3007 : 53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
2023/08/3007 : 17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
2023/08/3007 : 02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
 Showing the most relevant articles for your search:USOTC:SKYE

最近閲覧した銘柄

AMEX
XLV
Health Care Select Sector
NASDAQ
AAPL
Apple
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
VZ
Verizon Communications
NYSE
AXP
American Express
FX
USDGBP
US Dollar vs Sterling
USOTC
ADDYY
Adidas (QX)
NASDAQ
AMZN
Amazon.com
NYSE
CVX
Chevron
NYSE
XOM
Exxon Mobil
CCOM
US100
US Tech 100
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
MSFT
Microsoft
NYSE
MRK
Merck
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
NVDA
NVIDIA
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有